The proportion of patients taking a GLP-1 weight-loss drug following bariatric surgery increased substantially in recent years, although the timing of initiation after surgery varied widely, a large ...
Rates of overweight and obesity have more than doubled in the United States during the last three decades, according to a new analysis. By 2050, it’s anticipated that 213 million adults (age, > 25 ...
Credit: Getty Images In light of Serena Williams’s endorsement of GLP-1 medications, we interviewed an obesity medicine specialist about the implications of these medications for professional athletes ...
GLP-1 medications like Ozempic and Zepbound are transforming chronic disease and weight management, with perimenopausal women among the most common users. Despite their high use in this group, women ...
Employer cost coverage increases likelihood of GLP-1 use (65% overall), peaking in ages 35–44 (75%) and declining sharply among workers ≥65 (37%). Behavioral support programs shift willingness to self ...
Share on Pinterest An increasing number of people without diabetes are using GLP-1 agonist drugs for weight loss only. Image credit: MarkHatfield/Getty Images. The last few years have seen a marked ...
Julia Sullivan is a health and fitness writer, editor and content strategist well as a certified personal trainer. Her byline is in many publications from Harper's Bazaar to SELF Magazine to brand ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. GLP-1 use appears to be rising among patients with MASH ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results